IL15 and breast carcinoma: For example, in two studies using exosomes derived from NK-92 cells (one with IL-15 priming), the exosomes showed cytotoxic effects on melanoma (B16F10) and breast cancer (MDA-MB-231/F) cells that were abolished by anti-Fas antibody (8, 15).